ABSTRACT

Background
Indoor residual spraying (IRS) and long-lasting insecticidal nets (LLINs) are the primary tools for malaria prevention in Africa. It is not known whether reductions in malaria can be sustained after IRS is discontinued. The aim of this study was to assess changes in malaria morbidity in a historically high transmission area of Uganda where IRS was discontinued after a four-year period of effective control followed by a universal LLIN distribution campaign.
Methods
Individual-level malaria surveillance data were collected from one outpatient department and one 
Results
Data include 65,421 outpatient visits and 13,955 pediatric inpatient admissions for which a diagnostic test for malaria was performed. In outpatients under five years, baseline TPR was 60-80% followed by a rapid and then sustained decrease to 15-30%. Over 4-18 months following discontinuation of IRS, absolute TPR values increased by an average of 3.29% per month (95% CI 2.01-4.57%), returning to baseline levels. Similar trends were seen in outpatients over five years of age and pediatric admissions.
Conclusions
Discontinuation of IRS in a historically high transmission intensity area was associated with a
INTRODUCTION
Malaria control activities in sub-Saharan Africa have increased approximately twentyfold over the last decade resulting in substantial reductions in the burden of malaria [1] [2] [3] . Despite these advances, the burden of malaria remains high with an estimated 215 million cases and 438,000 deaths in 2015, of which 88% of cases and 90% of deaths occurred in sub-Saharan Africa [4] .
The primary interventions for the prevention of malaria include long-lasting insecticidal nets (LLINs) and indoor residual spraying of insecticide (IRS). LLINs have been shown to reduce malaria morbidity and mortality across a range of epidemiological settings, and the World Health Organization (WHO) recommends universal coverage of populations at risk [5, 6] . IRS has also been shown to be highly effective, but it is more resource-intensive to implement than distribution of LLINs and less than 10% of the population at risk in sub-Saharan Africa is currently protected by IRS [4, 7, 8] .
Uganda is emblematic of countries with the highest burden of malaria in sub-Saharan Africa, where progress in reducing malaria morbidity and mortality has been slowest. LLINs have been the primary intervention for the prevention of malaria in Uganda and considerable effort has been made to achieving universal LLIN coverage, culminating in a universal LLIN distribution campaign conducted from 2013-14. After decades of inactivity, IRS was adopted as a key component of Uganda's malaria control strategy in 2006 with funding from the President's Malaria Initiative. Initial efforts focused on epidemic prone areas in the southwestern part of the country. However, in 2008 the IRS program was moved to ten districts in northern Uganda with high transmission intensity. The IRS program in northern Uganda achieved coverage levels consistently above 95% and resulted in marked reductions in the burden of malaria [9, 10] . In 2014, the IRS program was moved from the ten districts in the north, with hopes that gains would mainly be sustained following the universal LLIN distribution campaign.
This study utilizes data from an enhanced health facility-based malaria surveillance program established in an outpatient and inpatient setting in Apac District, one of the areas in northern Uganda where IRS was implemented, and later withdrawn. The study spans a 77-month period from July 2009 through November 2015, covering ten rounds of IRS before its discontinuation in May 2014, followed by universal distribution of LLINs in June 2014. Our primary objective was to evaluate trends in malaria morbidity before, during, and after the implementation of IRS.
METHODS
Study site and vector control interventions
The study was conducted in Apac District, an area with historically high malaria transmission intensity; in 2002 the entomological inoculation rate was estimated to be over 1,500 infectious bites per person per year [11] . Malaria transmission is perennial in this area with peaks following the two annual rainy seasons. IRS was first implemented in Apac District in May 2008 with a single round of DDT followed by a 2 nd round conducted in February 2010 using the pyrethroid alpha-cypermethrin. Due to concerns around the emergence of pyrethroid resistance [10] 
Health facility-based surveillance
Enhanced malaria surveillance was conducted at one outpatient facility (Aduku Health Center) and one inpatient facility including children under 14 years of age (Apac Hospital) as previously described ( Figure 1 ) [13, 14] . Briefly, data were collected on demographics, whether malaria was suspected (outpatient facility only), whether a laboratory test for malaria was performed, the type estimates of monthly rainfall with a one month lag [15] , method of laboratory testing (microscopy vs. RDT) and autocorrelation. Outpatient surveillance data were stratified for patients under five and five years or older. Among inpatients with laboratory confirmed malaria, the probabilities of having complicated malaria, severe malaria, or death with malaria were compared between the periods of effective IRS and 4-18 months after IRS was discontinued using logistic regression controlling for age, monthly rainfall with a one month lag, and autocorrelation by including a quadratic term for the day of observation.
RESULTS
Characteristics of the study population
Over the 77-month observation period, there were 126,260 outpatient encounters of which 53.6%
were suspected of having malaria. Among patients with suspected malaria, 96.7% underwent laboratory testing. Laboratory testing was exclusively based on microscopy until 2012 when
RDTs became available at the health center. Initially RDT use was low, but increased to 29.4% during the 4-18 month period after IRS was discontinued. Following the implementation of IRS there was a shift to an older age range among patients suspected and tested for malaria that then returned to baseline after IRS was discontinued ( Table 2 ).
Over the 54-month inpatient observation period, 14,595 children were admitted to the hospital of which 95.6% underwent diagnostic testing for malaria. Among children tested for malaria, the proportion of testing based on RDTs was only 1.6% during the period of effective IRS, increasing to 33.0% during the 4-18 month period after IRS was discontinued. The age distribution of children admitted to the hospital was similar during the period before and after IRS was discontinued (Table 2) .
Temporal changes in malaria morbidity in relation to IRS
For the outpatient surveillance data, the baseline period, which included the one round of IRS with alpha-cypermethrin, which was not associated with a significant change in the TPR. During Table 3 ).
Of note, monthly estimates of rainfall with a one month lag time were controlled for in all analyses and there was no significant difference in average monthly rainfall in 2015 (mean Table 3 ). Despite the marked increase in TPR following discontinuation of IRS, there was no evidence for worsening of disease severity.
Comparing the 4-18 month period after IRS was discontinued to the sustained period of effective IRS, the probabilities of having complicated malaria (24.5% vs. 27.2%) and severe malaria (1.9% vs. 5.6%) were lower (p<0.0001 for both comparisons) and there was no significant change in the probability of death with malaria during hospitalization (0.3% vs. 0.5%, p=0.42).
DISCUSSION
In a district of Uganda with historically high malaria transmission intensity, the implementation of IRS with the carbamate bendiocarb was associated with a rapid decline in the malaria TPR among outpatients, followed by a sustained decline over a four-year period. Immediately following the discontinuation of IRS, a universal LLIN distribution campaign was conducted with the hopes that gains achieved by IRS would be maintained. However, TPRs began to rise four months after IRS was discontinued, reaching pre-IRS levels within 18 months. Similar trends were seen following discontinuation of IRS among children admitted to the district hospital, although there was no evidence of worsening in disease severity.
LLINs and IRS are the most widely used interventions for the prevention of malaria in Africa and the WHO recommends universal access to either of these measures [4] . The benefits of
LLINs have been well-established in randomized controlled trials, with use of LLINs associated with reductions in the incidence of malaria of 50% and child mortality of 20% [5] . It has been estimated that the incidence of malaria decreased by 40% across sub-Saharan Africa between 2000 and 2015, and that LLINs were responsible for 68% of cases averted [1] . In Uganda, the proportion of households with at least one LLIN increased from 47% to 90% between 2009-2014, and the average number of LLINs per household increased from 0.8 to 2.5 [12] .
Historically, IRS has played a major role in the elimination of malaria in several countries outside of Africa and in greatly reducing the burden of malaria in parts of Africa with low or seasonal transmission [16, 17] . Although the effectiveness of IRS has been well-established through historical and operational evidence, high-quality data from randomized controlled trials on the impact of IRS in stable transmission settings is limited [18] . Recent cluster randomized trials from Africa comparing IRS combined with LLINs versus either intervention alone have provided mixed results [19] [20] [21] . Adding IRS to LLINs appears to be most effective in areas where LLIN coverage is low, pyrethroid resistance is high, and/or when using IRS with nonpyrethroid based insecticides [22] .
In our study, the benefits of IRS with bendiocarb were clear as evidenced by the dramatic decline in malaria morbidity after its initiation followed by an equally dramatic increase shortly after IRS was discontinued. The resurgence of malaria occurred despite universal LLIN distribution immediately following discontinuation of IRS. These findings raise questions about whether the LLINs were used properly, or if insecticide resistance may have limited their effectiveness. The recent spread of pyrethroid resistance, the only class of insecticides currently available for LLINs, is of concern. The emergence of high-level pyrethroid resistance among the primary vectors, An. gambiae s.s. and An. arabiensis, has been reported in Uganda and other parts of Africa [23, 24] . Also of concern are putative changes in vector behavior and shifts in the relative abundance of vector species, which may increase exposure risk during the early evening hours while people are outside of their bed nets and unprotected by LLINs [25] . One reassuring finding from our study was the lack of an increased risk of severe or complicated malaria among pediatric inpatients during the resurgence of malaria following discontinuation of IRS. However, following the discontinuation of IRS, the TPR among outpatients 5 years and older increased to levels higher than those observed before the initiation of effective IRS, suggesting a loss of some immunity against uncomplicated malaria.
In withdrawal of IRS was a major contributing factor, but this was felt to be primarily due to resource constraints or complacency rather than insecticide resistance [27] . In a cross-case study review, premature reductions of coverage or withdrawal of IRS were linked to malaria resurgence in Cape Verde, Sri Lanka, and Turkey [28] . Contemporary data from Africa on the impact of discontinuing IRS is limited given that this has been a recent phenomenon. In the high transmission region of Northeastern Zambia, but not in the rest of the country where transmission is lower, a resurgence of malaria cases was reported following disruption of IRS [29] ; in two districts of Tanzania an increase in parasite prevalence was reported following the discontinuation of IRS after four years despite distribution of LLINs [26] ; and in Benin an increase in entomological measures of transmission was reported following the discontinuation of IRS after three years despite distribution of LLINs [30] . In contrast, following a 3-year experimental program of IRS in South Pare, Tanzania, which ended in 1959, the expected resurgence of malaria was delayed for several years which was attributed to changes brought about in the original vector mosquito populations and a program to increase the use of antimalarial drugs [31] .
Our study had several limitations. Most importantly were the observational study design and the lack of a control group. Thus, we are unable to exclude the possibility that factors other than the discontinuation of IRS contributed to the resurgence of malaria seen. For example, adherence to
LLINs was not measured, therefore although LLIN coverage was reportedly high, it is unknown whether they were sufficient numbers of LLINs and they were being used properly. In addition, the availability of ACTs was not measured and stock outs could have contributed to the resurgence. Another potential limitation was use of the TPR as our outcome measure, which is a surrogate measure of malaria incidence and can be influenced by factors such as health facility attendance, selection bias for those referred for testing, and the accuracy of laboratory testing.
Despite these limitations, it is likely that the observed changes in malaria morbidity were related to starting and stopping effective IRS given the longitudinal nature of the data, the magnitude of changes, and the consistency with which data was collected over an extended period of time. It should also be pointed out that our study area bordered several districts where IRS was not implemented (Figure 1 ), which may have contributed to the rapid resurgence of malaria.
Uganda and other countries in Africa are now facing difficult decisions about the role of IRS when demands exceed the availability of resources. Current funding levels are insufficient to measures are withdrawn. In addition, the emergence of pyrethroid resistance has required countries to consider alternative classes of insecticide, which can be considerably more expensive. There is an urgent need to better define when IRS should be maintained, changed to different formulations, or can be safely discontinued or scaled back. This will require effective surveillance systems to monitor trends in disease burden and insecticide resistance. In this area 
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